Literature DB >> 25736362

MicroRNA-124 involves in ankylosing spondylitis by targeting ANTXR2.

Yu Xia1, Kun Chen, Ming-Hua Zhang, Lai-Cheng Wang, Chun-Yan Ma, Yan-Liang Lin, Yue-Ran Zhao.   

Abstract

OBJECTIVES: A recent genome-wide association study or GWAS identified that anthrax roxin receptor 2 (ANTXR2) was one of the risk loci for ankylosing spondylitis (AS). Previous study also showed that ANTXR2 could potentially affect new bone formation. This study aimed to investigate the possible mechanisms of ANTXR2 involved in AS pathogenesis.
METHODS: The expression level of ANTXR2 and miR-124 in peripheral blood was detected by quantitative real-time polymerase chain reaction or qRT-PCR. ANTXR2 was predicted to be a target gene of miR-124 by TargetScan, which was confirmed by luciferase reporter assays. Western blot analysis was used to further investigate the effect of miR-124 on c-Jun N-terminal kinase (JNK) activation and evaluate the activated status of autophagy.
RESULTS: We evidenced that ANTXR2 was downregulated and miR-124 was upregulated in peripheral blood from AS patients. Intriguingly, miR-124 targeted ANTXR2 and overexpression of miR-124 in Jurkat cells notably inhibited ANTXR2 expression. ANTXR2 inhibition by miR-124 promoted JNK activation and induced autophagy.
CONCLUSIONS: Our results suggested that miR-124 might induce autophagy to participate in AS by targeting ANTXR2, which might be implicated in pathological process of AS.

Entities:  

Keywords:  ANTXR2; Ankylosing Spondylitis; Autophagy; JNK; miR-124

Mesh:

Substances:

Year:  2015        PMID: 25736362     DOI: 10.3109/14397595.2015.1023887

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  9 in total

Review 1.  Expression and Metabolomic Profiling in Axial Spondyloarthritis.

Authors:  Darren D O'Rielly; Guangju Zhai; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2018-06-27       Impact factor: 4.592

Review 2.  Ankylosis in ankylosing spondylitis: current concepts.

Authors:  Nigil Haroon
Journal:  Clin Rheumatol       Date:  2015-06       Impact factor: 2.980

Review 3.  Autophagy in the pathogenesis of ankylosing spondylitis.

Authors:  Francesco Ciccia; Nigil Haroon
Journal:  Clin Rheumatol       Date:  2016-04-13       Impact factor: 2.980

4.  Nicotine protects against DSS colitis through regulating microRNA-124 and STAT3.

Authors:  Zhen Qin; Jing-Jing Wan; Yang Sun; Tingyu Wu; Peng-Yuan Wang; Peng Du; Ding-Feng Su; Yili Yang; Xia Liu
Journal:  J Mol Med (Berl)       Date:  2016-10-05       Impact factor: 4.599

Review 5.  The Role of MicroRNAS in Ankylosing Spondylitis.

Authors:  Zheng Li; Sunny H Wong; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 6.  Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases.

Authors:  Marzena Ciechomska; Steven O'Reilly
Journal:  Mediators Inflamm       Date:  2016-08-10       Impact factor: 4.711

7.  Circ_0018168 inhibits the proliferation and osteogenic differentiation of fibroblasts in ankylosing spondylitis via regulating miR-330-3p/DKK1 axis.

Authors:  Lei Zhao; Jiaxun Jiao; Guanghui Yan; Wei Wei; Genqiang Fang; Tiemiao Yu
Journal:  Regen Ther       Date:  2022-07-18       Impact factor: 3.651

Review 8.  MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis.

Authors:  Francesca Motta; Andrea Pederzani; Maria Cristina Carena; Angela Ceribelli; Paul B Wordsworth; Maria De Santis; Carlo Selmi; Matteo Vecellio
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

Review 9.  miRNA-124 in Immune System and Immune Disorders.

Authors:  Zhen Qin; Peng-Yuan Wang; Ding-Feng Su; Xia Liu
Journal:  Front Immunol       Date:  2016-10-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.